115 related articles for article (PubMed ID: 10913749)
1. Water-activated, pH-controlled patch in transdermal administration of timolol. I. Preclinical tests.
Sutinen R; Paronen P; Urtti A
Eur J Pharm Sci; 2000 Jul; 11(1):19-24. PubMed ID: 10913749
[TBL] [Abstract][Full Text] [Related]
2. Water-activated, pH-controlled patch in transdermal administration of timolol. II. Drug absorption and skin irritation.
Sutinen R; Paronen P; Saano V; Urtti A
Eur J Pharm Sci; 2000 Jul; 11(1):25-31. PubMed ID: 10913750
[TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of timolol by electroporation through human skin.
Denet AR; Préat V
J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332
[TBL] [Abstract][Full Text] [Related]
4. Iontophoretic enhancement of timolol across human dermatomed skin in vitro.
Fatouros DG; Bouwstra JA
J Drug Target; 2004 Jan; 12(1):19-24. PubMed ID: 15203908
[TBL] [Abstract][Full Text] [Related]
5. Experimental verification of the mechanistic model for transdermal transport including iontophoresis.
Hirvonen J; Murtomäki L; Kontturi K
J Control Release; 1998 Dec; 56(1-3):169-74. PubMed ID: 9801440
[TBL] [Abstract][Full Text] [Related]
6. Design and Evaluation of Transdermal Patches of Timolol Maleate.
Panchayya Hiremath SS; Reddy JJ; Jamakandi VG
Curr Drug Deliv; 2018; 15(5):658-663. PubMed ID: 28969565
[TBL] [Abstract][Full Text] [Related]
7. [Transdermal properties of timolol and factors affecting its permeability in vitro].
Xu YZ; Xu HN
Yao Xue Xue Bao; 1992; 27(6):467-71. PubMed ID: 1442076
[TBL] [Abstract][Full Text] [Related]
8. Comparison between the iontophoretic and passive transdermal delivery of timolol maleate across human cadaver skin.
Soni S; Dixit VK
Pharmazie; 1994 Jan; 49(1):73-4. PubMed ID: 8140139
[No Abstract] [Full Text] [Related]
9. Novel transdermal delivery of Timolol maleate using sugar esters: preclinical and clinical studies.
El-Laithy HM
Eur J Pharm Biopharm; 2009 May; 72(1):239-45. PubMed ID: 19126429
[TBL] [Abstract][Full Text] [Related]
10. Finite dose percutaneous drug absorption: theory and its application to in vitro timolol permeation.
Kubota K; Yamada T
J Pharm Sci; 1990 Nov; 79(11):1015-9. PubMed ID: 2292763
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of a hydroxypropyl cellulose gel system for transdermal delivery of timolol.
Stamatialis DF; Rolevink HH; Gironès M; Nymeijer DC; Koops GH
Curr Drug Deliv; 2004 Oct; 1(4):313-9. PubMed ID: 16305393
[TBL] [Abstract][Full Text] [Related]
12. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
Panda A; Sharma PK; Narasimha Murthy S
AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
[TBL] [Abstract][Full Text] [Related]
13. Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface.
Simon L; Ospina J
Math Biosci; 2013 Jul; 244(1):58-67. PubMed ID: 23624255
[TBL] [Abstract][Full Text] [Related]
14. In vitro transdermal iontophoretic transport of timolol maleate: effect of age and species.
Kanikkannan N; Singh J; Ramarao P
J Control Release; 2001 Mar; 71(1):99-105. PubMed ID: 11245911
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
16. [The bioavailability of transdermal therapeutic system of timolol].
Ji XF; Ping QN; Liu GJ; Yu ST
Yao Xue Xue Bao; 1993; 28(8):609-13. PubMed ID: 8285070
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and beta-blocking effects of transdermal timolol.
Kubota K; Yamada T; Kikuchi K; Koyama E; Ishizaki T
Eur J Clin Pharmacol; 1993; 44(5):493-5. PubMed ID: 8359190
[TBL] [Abstract][Full Text] [Related]
18. An analytical solution for percutaneous drug absorption: application and removal of the vehicle.
Simon L; Loney NW
Math Biosci; 2005 Oct; 197(2):119-39. PubMed ID: 16135370
[TBL] [Abstract][Full Text] [Related]
19. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
[TBL] [Abstract][Full Text] [Related]
20. Formulation study of a patch containing propranolol by design of experiments.
Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Selmin F; Montanari L
Drug Dev Ind Pharm; 2014 Jan; 40(1):17-22. PubMed ID: 23301830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
